Double Helix Bio-technology Development Overview
- Founded
- 1995
- Status
- Acquired/Merged
- Employees
- 51
- Latest Deal Type
- M&A
- Financing Rounds
- 1
Double Helix Bio-technology Development General Information
Description
Provider of market research and consulting services to the healthcare industry. The company offers market research, data analytic, market advisory, planning and consulting, strategy management and pharmaceutical market information services to the healthcare organizations.
Contact Information
Website
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Healthcare Services
Other Industries
Consulting Services (B2B)
Other Commercial Services
Acquirer
McCann Health
Primary Office
- 88 Baker Street
- London W1U 6TQ
- England, United Kingdom
Double Helix Bio-technology Development Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Double Helix Bio-technology Development‘s full profile, request access.
Request a free trialDouble Helix Bio-technology Development Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Charlie Buckwell | Chief Executive Officer | ||
| Jim Goldenberg | President |
Double Helix Bio-technology Development Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial